Companies
Beijing OriginWater
its membrane bioreactors anchor large industrial and municipal plants, combining activated-sludge biology with submerged membranes for high-quality reuse water under zero-liquid-discharge rules.
- Country
- China
- Ticker
- 300070
GB 18918
Zero-liquid-discharge
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| bioremediation | ✓ | ✓ | ✓ | ✓ |
Regulatorsepareachademe
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 2001 | weilanwaters.com |
| Headquarters | Beijing, China | globaldata.com · weilanwaters.com |
| Production site | Beijing and Tianjin, China | file.finance.sina.com.cn |
| Capacity | 20 million sqm/year for MF/UF membranes, 19 million sqm/year for NF/RO membranes, and 10,000 sets/year for lithium adsorbent equipment | file.finance.sina.com.cn |
| Certification | Domestic elements are WQA certified and MBR membrane products have passed international industry certification standards medium confidence | originwatermem.com |
| Regulatory approval | Key technologies included in the National Encouraged Environmental Protection Equipment list and major science/technology programs for water pollution control | en.originwater.com · file.finance.sina.com.cn |
| Headcount | 4,301 employees | globaldata.com |
| Revenue | 7.78 billion CNY (2025) | static.cninfo.com.cn · money.finance.sina.com.cn |
Independent sources: file.finance.sina.com.cn · globaldata.com · money.finance.sina.com.cn · static.cninfo.com.cn · weilanwaters.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioremediation of hazardous industrial effluents (metal bio-precipitation, MBR, enzymatic dye & phenol degradation) | bioremediation | Medium | → |
| Microbial bioremediation (enzymatic degradation, PFAS destruction, MBR wastewater) | bioremediation | Medium | → |
| Municipal wastewater bio-treatment | bioremediation | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.